Casey Tansey - Inspire Medical Independent Director
| INSP Stock | USD 152.37 2.92 1.88% |
Director
Mr. Casey M. Tansey serves as independent Director of the Company since January 2008. Since August 2014, Mr. Tansey has served as a Managing Partner of U.S. Venture Partners, a VC investment firm, and, from April 2005 to July 2014, as a Managing Member of USVP. Mr. Tansey previously served on the board of directors of Intersect ENT, Inc. from 2006 to 2017 and Reshape Medical, Inc. from October 2008 to October 2017 since 2008.
| Age | 63 |
| Tenure | 16 years |
| Professional Marks | MBA |
| Address | 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 |
| Phone | 844 672 4357 |
| Web | https://www.inspiresleep.com |
Inspire Medical Management Efficiency
The company has return on total asset (ROA) of (0.0358) % which means that it has lost $0.0358 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0288) %, meaning that it created substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 05/22/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 05/22/2024, Liabilities And Stockholders Equity is likely to grow to about 710.7 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| John Stratton | Abbott Laboratories | 60 | |
| Michelle Kumbier | Abbott Laboratories | 53 | |
| Samuel Scott | Abbott Laboratories | 75 | |
| Daniel Starks | Abbott Laboratories | 66 | |
| Robert Alpern | Abbott Laboratories | 70 | |
| Srikant Datar | Stryker | 68 | |
| Andrew Silvernail | Stryker | 50 | |
| William Osborn | Abbott Laboratories | 73 | |
| Edward Liddy | Abbott Laboratories | 74 | |
| Glenn Tilton | Abbott Laboratories | 72 | |
| Roxanne Austin | Abbott Laboratories | 60 | |
| Nancy McKinstry | Abbott Laboratories | 62 | |
| Giovanni Caforio | Stryker | 56 | |
| Roch Doliveux | Stryker | 64 | |
| Mary Brainerd | Stryker | 67 | |
| Rajeev Suri | Stryker | 53 | |
| Darren McDew | Abbott Laboratories | 60 | |
| Sherilyn McCoy | Stryker | 62 | |
| Patricia Gonzalez | Abbott Laboratories | 49 | |
| Ronda Stryker | Stryker | 66 | |
| Sally Blount | Abbott Laboratories | 59 | |
Management Performance
| Return On Equity | -0.0288 | ||||
| Return On Asset | -0.0358 |
Inspire Medical Systems Leadership Team
Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgia GarinoisMelenikiotou, Independent Director | ||
| Megan CPA, Director Reporting | ||
| Timothy Herbert, President, Chief Executive Officer, Director | ||
| Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources | ||
| Philip Ebeling, Chief Operating Officer | ||
| Ezgi Yagci, Vice Relations | ||
| Andreas Henke, Senior Europe | ||
| Casey Tansey, Independent Director | ||
| Richard Buchholz, Chief Financial Officer | ||
| Kathy Sherwood, Senior Access | ||
| Martin Abrams, Vice Experience | ||
| Gary Ellis, Independent Director | ||
| John Rondoni, Chief Officer | ||
| Shawn McCormick, Independent Director | ||
| Carlton Weatherby, Chief Officer | ||
| Randall Ban, Senior Vice President Global Sales and Marketing | ||
| Dana Mead, Independent Director | ||
| Shelley Broader, Independent Director | ||
| Ivan Lubogo, Senior Sales | ||
| Georgia Melenikiotou, Independent Director | ||
| MD FAAOS, Chief Officer | ||
| Marilyn Nelson, Independent Chairman of the Board | ||
| Jerry Griffin, Independent Director | ||
| Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary |
Inspire Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0288 | ||||
| Return On Asset | -0.0358 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 4.11 B | ||||
| Shares Outstanding | 29.71 M | ||||
| Shares Owned By Insiders | 1.97 % | ||||
| Shares Owned By Institutions | 98.03 % | ||||
| Number Of Shares Shorted | 2.3 M | ||||
| Price To Earning | 15.29 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Inspire Stock analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Inspire Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inspire Medical. If investors know Inspire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inspire Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.682 | Earnings Share (0.53) | Revenue Per Share 22.454 | Quarterly Revenue Growth 0.282 | Return On Assets (0.04) |
The market value of Inspire Medical Systems is measured differently than its book value, which is the value of Inspire that is recorded on the company's balance sheet. Investors also form their own opinion of Inspire Medical's value that differs from its market value or its book value, called intrinsic value, which is Inspire Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inspire Medical's market value can be influenced by many factors that don't directly affect Inspire Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.